Search
for
Sort by
Research 121–150 of 1000+
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Skin Disease in Korean Human Immunodeficiency Virus Patient
- Nonhuman primate dermatology: a literature review
- Topical and transdermal lipid-polymer hybrid nanoparticles (LPN): an integration in advancing dermatological treatments
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- JAK Inhibitors for Treatment of Alopecia Areata
- Herbal Treatment for Dermatologic Disorders
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Madarosis
- Farmácia Lusitana, Vila do Conde e nos Serviços Farmacêuticos do Hospital CUF, Porto
- Topical use of systemic drugs in dermatology: A comprehensive review
- Folliculitis
- Unconventional medicine in dermatology outpatients in Turkey
- Skin, a mirror reflecting diabetes mellitus: A longitudinal study in a tertiary care hospital in Gujarat
- Hair loss
- Subject Index
- Cutaneous manifestations of COVID-19
- Mixing the Old with the New: Drug Repurposing for Immune Deficiency in the Era of Precision Medicine and Pediatric Genomics
- Prevalence of Skin Conditions Among Pediatric Patients in the Region of Istanbul
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Skin disease in pregnancy
- Skin Disorders
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- CLINICAL STUDY OF CUTANEOUS MANIFESTATION OF GERIATRIC AGE GROUP
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Efficacy and safety of tofacitinib in patients with alopecia areata